$95.55 Nov 18, 2026 · market cap $7.5B
Kiniksa Pharmaceuticals International trades at $96. Our two models put it at $42–$106 (base $42): 128% above the base.
Cash Flow $106 · Buffett $42 · models run Nov 18, 2026
8 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app